Skip to content

Clinical trials

Phase 2 HIV Seropositivity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: HIV Seropositivity Phase: Phase 2 Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20051
20061
20082
20103
20112
20121
20141
20181
20191
20222
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting2
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AIM ImmunoTech Inc.2
National Institute of Allergy and Infectious Diseases (NIAID)2
AIDS Malignancy Consortium1
Bayside Health1
BiondVax Pharmaceuticals ltd.1
Centre Hospitalier Régional d'Orléans1
Columbia University1
Federal University of São Paulo1
Friends Research Institute, Inc.1
ImmunityBio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
HIV Seropositivity20
HIV Infections6
Acquired Immunodeficiency Syndrome2
Burkitt Lymphoma1
Carcinoma, Non-Small-Cell Lung1
Diarrhea1
Hodgkin Disease1
Influenza, Human1
Lupus Erythematosus, Systemic1
Lymphoma, Large B-Cell, Diffuse1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.